Dr Michael Winlo, chief executive of Emerald Clinics since August 2019, was chief executive of Linear Clinical Research for 3 years and remained on the board from July 2019 when he stepped down from the CEO role to lead a startup company in digital health innovation. Linear Clinical Research is the clinical trials arm of the Harry Perkins Institute of Medical Research.
He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years in the US growing the health practice of data analysis firm Palantir Technologies.
Dr Winlo holds a Bachelor of Medicine and Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of Business.